Accendra Health Inc (ACH) stock
ACHNYSEWholesale-Medical, Dental & Hospital Equipment & SuppliesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/3098% below fair value
$0.13−0.01 (-9.59%)
Close on Nov 13, 2026Market cap $10.15MP/E –Yield –
Accendra Health r&d expenses
Research and development expenses are spending on new products and technology.
For fiscal 2024 it was $13.00M, up 0.0% from the year before.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $13.00M | 0.0% |
| FY2023 | Dec 31, 2023 | $13.00M | +8.3% |
| FY2022 | Dec 31, 2022 | $12.00M | -0.8% |
| FY2021 | Dec 31, 2021 | $12.10M | – |
See a number that looks wrong?